Sana Biotechnology, Inc. (SANA) — Institutional Holders, Q2 2026 (page 3)

213 institutional investment managers reported a SANA position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $644.6M. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 201 to 213. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

SANA 13F holders ranked 201–213 of 213

Institutional investors reporting a position in Sana Biotechnology, Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
Optiver Holding B.V.#201 · 357 sh$1.2K-36.4%
State of Wyoming#202 · 307 sh$1.1KNew
NORTHWESTERN MUTUAL WEALTH MANAGEMENT#203 · 200 sh$698.00New
Rialto Wealth Management#204 · 145 sh$507.00New
US BANCORP \DE\#205 · 107 sh$373.00-84.6%
BARTLETT & WEALTH MANAGEMENT#206 · 100 sh$349.000.0%
CREATIVE FINANCIAL DESIGNS#207 · 100 sh$349.000.0%
HOLLENCREST SECURITIES#208 · 50 sh$175.00New
Axiom Investment Management#209 · 20 sh$70.00New
Keating Financial Advisory Services#210 · 1 sh$3.00New
Activest Wealth Management#211 · 0 sh$0.00-100.0%
Covestor Ltd#212 · 87 sh$0.00+234.6%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM#213 · 181,749 sh—+11.1%

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.